Cargando…

The L-Type Amino Acid Transporter LAT1—An Emerging Target in Cancer

Chronic proliferation is a major hallmark of tumor cells. Rapidly proliferating cancer cells are highly dependent on nutrients in order to duplicate their cell mass during each cell division. In particular, essential amino acids are indispensable for proliferating cancer cells. Their uptake across t...

Descripción completa

Detalles Bibliográficos
Autores principales: Häfliger, Pascal, Charles, Roch-Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566973/
https://www.ncbi.nlm.nih.gov/pubmed/31100853
http://dx.doi.org/10.3390/ijms20102428
_version_ 1783426969134694400
author Häfliger, Pascal
Charles, Roch-Philippe
author_facet Häfliger, Pascal
Charles, Roch-Philippe
author_sort Häfliger, Pascal
collection PubMed
description Chronic proliferation is a major hallmark of tumor cells. Rapidly proliferating cancer cells are highly dependent on nutrients in order to duplicate their cell mass during each cell division. In particular, essential amino acids are indispensable for proliferating cancer cells. Their uptake across the cell membrane is tightly controlled by membrane transporters. Among those, the L-type amino acid transporter LAT1 (SLC7A5) has been repeatedly found overexpressed in a vast variety of cancers. In this review, we summarize the most recent advances in our understanding of the role of LAT1 in cancer and highlight preclinical studies and drug developments underlying the potential of LAT1 as therapeutic target.
format Online
Article
Text
id pubmed-6566973
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-65669732019-06-17 The L-Type Amino Acid Transporter LAT1—An Emerging Target in Cancer Häfliger, Pascal Charles, Roch-Philippe Int J Mol Sci Review Chronic proliferation is a major hallmark of tumor cells. Rapidly proliferating cancer cells are highly dependent on nutrients in order to duplicate their cell mass during each cell division. In particular, essential amino acids are indispensable for proliferating cancer cells. Their uptake across the cell membrane is tightly controlled by membrane transporters. Among those, the L-type amino acid transporter LAT1 (SLC7A5) has been repeatedly found overexpressed in a vast variety of cancers. In this review, we summarize the most recent advances in our understanding of the role of LAT1 in cancer and highlight preclinical studies and drug developments underlying the potential of LAT1 as therapeutic target. MDPI 2019-05-16 /pmc/articles/PMC6566973/ /pubmed/31100853 http://dx.doi.org/10.3390/ijms20102428 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Häfliger, Pascal
Charles, Roch-Philippe
The L-Type Amino Acid Transporter LAT1—An Emerging Target in Cancer
title The L-Type Amino Acid Transporter LAT1—An Emerging Target in Cancer
title_full The L-Type Amino Acid Transporter LAT1—An Emerging Target in Cancer
title_fullStr The L-Type Amino Acid Transporter LAT1—An Emerging Target in Cancer
title_full_unstemmed The L-Type Amino Acid Transporter LAT1—An Emerging Target in Cancer
title_short The L-Type Amino Acid Transporter LAT1—An Emerging Target in Cancer
title_sort l-type amino acid transporter lat1—an emerging target in cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566973/
https://www.ncbi.nlm.nih.gov/pubmed/31100853
http://dx.doi.org/10.3390/ijms20102428
work_keys_str_mv AT hafligerpascal theltypeaminoacidtransporterlat1anemergingtargetincancer
AT charlesrochphilippe theltypeaminoacidtransporterlat1anemergingtargetincancer
AT hafligerpascal ltypeaminoacidtransporterlat1anemergingtargetincancer
AT charlesrochphilippe ltypeaminoacidtransporterlat1anemergingtargetincancer